Legal & General Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-169
| Closed | -$4.54K | – | 3556 |
|
|
2023
Q1 | $4.54K | Hold |
169
| – | – | ﹤0.01% | 3312 |
|
|
2022
Q4 | $5.98K | Hold |
169
| – | – | ﹤0.01% | 3333 |
|
|
2022
Q3 | $38K | Buy |
169
+25
| +17% | +$5.62K | ﹤0.01% | 3044 |
|
|
2022
Q2 | $27K | Buy |
144
+55
| +62% | +$10.3K | ﹤0.01% | 3142 |
|
|
2022
Q1 | $22K | Hold |
89
| – | – | ﹤0.01% | 3222 |
|
|
2021
Q4 | $14K | Hold |
89
| – | – | ﹤0.01% | 3393 |
|
|
2021
Q3 | $18K | Hold |
89
| – | – | ﹤0.01% | 3321 |
|
|
2021
Q2 | $23K | Sell |
89
-29
| -25% | -$7.49K | ﹤0.01% | 3253 |
|
|
2021
Q1 | $31K | Sell |
118
-4
| -3% | -$1.05K | ﹤0.01% | 2983 |
|
|
2020
Q4 | $45K | Buy |
122
+11
| +10% | +$4.06K | ﹤0.01% | 2832 |
|
|
2020
Q3 | $27K | Sell |
111
-21
| -16% | -$5.11K | ﹤0.01% | 2885 |
|
|
2020
Q2 | $38K | Sell |
132
-1
| -0.8% | -$288 | ﹤0.01% | 2809 |
|
|
2020
Q1 | $27K | Sell |
133
-28
| -17% | -$5.68K | ﹤0.01% | 2809 |
|
|
2019
Q4 | $72K | Buy |
161
+31
| +24% | +$13.9K | ﹤0.01% | 2692 |
|
|
2019
Q3 | $40K | Hold |
130
| – | – | ﹤0.01% | 2833 |
|
|
2019
Q2 | $41K | Buy |
+130
| New | +$41K | ﹤0.01% | 2860 |
|
|
2017
Q2 | – | Sell |
-31
| Closed | -$10K | – | 3394 |
|
|
2017
Q1 | $10K | Hold |
31
| – | – | ﹤0.01% | 3195 |
|
|
2016
Q4 | $10K | Buy |
+31
| New | +$10K | ﹤0.01% | 3215 |
|